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One of the most compelling aspects of the COVID-19 pandemic 
as been its uneven global impact. Once the scale of the COVID- 
9 epidemic in Wuhan became clear, large outbreaks were ex- 
ected to follow in neighboring Asian states [1] . However, due to 
 combination of effective public health interventions, transmis- 
ion of SARS-CoV-2 was largely suppressed. By the end of Septem- 
er 2020, just over 500 COVID-19 related deaths had been re- 
orted across mainland South East Asia, while hundreds of thou- 
ands were dying in Europe and the Americas. 
Lao Peoples Democratic Republic (Lao PDR) has limited public 
ealth infrastructure but reported a particularly low burden of dis- 
ase. Despite bordering China, it was the last country in South East 
sia to report a confirmed case of COVID-19. The government im- 
lemented a national lockdown soon after and closed all land bor- 
ers. By September 2020, months after schools and travel networks 
ad reopened, only 23 cases had been identified. The first COVID- 
9–related death was not reported until 9 th May 2021. 
In low resource settings, the accuracy of routinely reported case 
umbers and deaths may be difficult to verify. For example, Peru 
ore than doubled its official COVID-19 death toll due to an under- 
ount attributed to a lack of testing [2] . Lao PDR’s reported case 
umbers are based on the swabbing of symptomatic individuals 
nd foreign arrivals, which could result in under-reporting of min- 
mally or asymptomatic cases in the community. Alternative meth- 
ds of surveillance, such as sero-surveys are therefore essential 
ools for monitoring the pandemic. 
To address whether SARS-CoV-2 may have circulated more 
idely in the first months of the pandemic, Virachith and col- 
eagues conducted an extensive SARS-CoV-2 antibody seropreva- 
ence survey in Lao PDR in August and September 2020 [3] . They ∗ Corresponding author. 
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embers of the general community, healthcare workers and in- 
ividuals who work closely with bats and rural wildlife in Vien- 
iene province. The latter in particular, represents a population of 
onsiderable interest, given that bats and rodents in the region are 
requently infected with a diverse array of alpha- and beta- coron- 
viruses, including SARS-CoV-2–like viruses [4] . 
The study is the largest SARS-CoV-2 antibody survey in South 
ast Asia to date and provides the first estimation of community 
eroprevalence in the region. They found only 0.1% individuals sur- 
eyed had antibodies to both SARS-CoV-2 nucleoprotein and spike 
rotein. Both individuals tested negative by lateral flow immunoas- 
ay and probably represent false positives. By comparison, all sam- 
les from COVID-19-cases identified by national COVID-19 surveil- 
ance in Lao PDR (n = 15) were seropositive by both ELISA and rapid 
iagnostic tests. Given the breadth of the study, the data strongly 
upports the hypothesis that there was minimal SARS-Co-V-2 cir- 
ulation in Lao-PDR up to September 2020. 
The study also found that antibodies against nucleoprotein were 
ore prevalent in villagers employed in harvesting bat guano 
20%) than in the general population (5%) or health care workers 
2%). Nucleoprotein is more conserved across coronaviruses than 
pike protein and this finding likely represents cross-reactivity 
ith non-SARSCoV2 coronaviruses. Data from other settings sug- 
est these cross-reactive antibodies do not offer protection from 
OVID-19 [5] . Although nucleoprotein antibody prevalence in Lao 
DR probably has no relevance to its successful suppression of 
OVID-19, the elevated prevalence in bat guano collectors does 
mply that specific rural populations have significant exposure to 
oronaviruses, representing an ongoing risk for emergence of fu- 
ure pandemics. 
A major strength of this study is the sampling strategy. Previous 
urveys have been compromised by selection bias, including non- 
andom, unrepresentative sampling [6] , substantial dropout [7] , or under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 





























onvenience sampling [8] , Virachith et al use a multistage cluster 
ampling design with random selection of districts within five sep- 
rate provinces and report minimal voluntary drop out. Some bias 
ay have arisen from ‘unavailable’ individuals being replaced by 
ther randomized participants, who may have a lower risk of ex- 
osure to COVID-19 by virtue of not being at work or school. Over- 
ll, however, the randomized nature of the sampling and the very 
ow antibody prevalence limits the impact of this bias. 
The findings are in keeping with data from Lao PDR’s South 
ast Asian neighbours [9–11] . Taken together this data illustrates 
hat there was no widespread silent transmission of SARS-CoV-2 in 
outh East Asia in 2020 and re-affirms that these countries’ success 
n limiting deaths from COVID-19 is due to effective suppression of 
ARS-CoV-2 transmission, through timely public health interven- 
ions. However, for Lao PDR and its neighbors the battle is far from 
ver. Since April 2021 there has been sustained community trans- 
ission of SARS-CoV-2 throughout South East Asia even in coun- 
ries which had successfully suppressed transmission throughout 
020. Vaccination coverage remains woefully inequitable with al- 
ost all doses administered in a small number of high-income 
ountries. As high vaccination coverage is likely the only sustain- 
ble strategy to suppress SARS-CoV-2 transmission in the long 
erm and reduce the ongoing risk of new variants emerging ad- 
ressing this vaccination-gap must be a priority. 
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